Compare CARR & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CARR | EW |
|---|---|---|
| Founded | 2019 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.1B | 48.9B |
| IPO Year | 2020 | 1999 |
| Metric | CARR | EW |
|---|---|---|
| Price | $63.95 | $88.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 21 |
| Target Price | $70.62 | ★ $96.37 |
| AVG Volume (30 Days) | ★ 6.9M | 5.0M |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.55% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.28 | ★ 1.07 |
| Revenue | ★ $21,747,000,000.00 | $6,067,600,000.00 |
| Revenue This Year | $2.91 | $13.39 |
| Revenue Next Year | $5.37 | $9.81 |
| P/E Ratio | $233.68 | ★ $83.15 |
| Revenue Growth | N/A | ★ 11.55 |
| 52 Week Low | $50.24 | $72.30 |
| 52 Week High | $76.76 | $96.29 |
| Indicator | CARR | EW |
|---|---|---|
| Relative Strength Index (RSI) | 48.10 | 55.32 |
| Support Level | $65.77 | $81.88 |
| Resistance Level | $69.53 | $96.29 |
| Average True Range (ATR) | 2.12 | 2.26 |
| MACD | -0.05 | 0.47 |
| Stochastic Oscillator | 63.30 | 78.41 |
Carrier Global, spun out of United Technologies in 2020, manufactures and services commercial and residential HVAC systems and transportation refrigeration solutions under its flagship Carrier brand, as well as Bryant, Payne, Heil, and others across various price points. In 2024, Carrier acquired Viessmann Climate Solutions to expand its footprint in Europe with heat pumps, boilers, and solar PV equipment. Proceeds from the sale of Carrier's fire and security (Honeywell) and commercial refrigeration (Haier) businesses reduced debt and focused the company on global HVAC and refrigeration solutions. Carrier generates 75% of sales from equipment and 25% from parts and services. The company derives 50% of revenue from the US, 30% from Europe, and 20% from the Asia-Pacific region.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.